The Lancet Diabetes & Endocrinology in conversation with podcast

Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma

0:00
9:42
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma. Read the full article: Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma

Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

The Lancet Diabetes & Endocrinology in conversation with...  is part of the Lancet Group podcast offering. 

Editorial team: Marta Koch, David Holmes, and Susan Rahimi

Podcast editing and production: Matteo Simonetti

Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering. 

Find the best science for better lives at https://www.thelancet.com/journals/landia/home Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Flere episoder fra "The Lancet Diabetes & Endocrinology in conversation with"